Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon

The exacerbation of antimicrobial resistance (AMR) is a major public health threat worldwide. In sub-Saharan Africa, there is a scarcity of data regarding multidrug-resistant (resistance to at least one antibiotic of three or more families of antibiotics) as well as extended spectrum β-lactamase-pro...

Full description

Bibliographic Details
Main Authors: Ravalona Jessica Zemtsa, Michel Noubom, Luria Leslie Founou, Brice Davy Dimani, Patrice Landry Koudoum, Aurelia Djeumako Mbossi, Charles Kouanfack, Raspail Carrel Founou
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/5/504
_version_ 1797497061534334976
author Ravalona Jessica Zemtsa
Michel Noubom
Luria Leslie Founou
Brice Davy Dimani
Patrice Landry Koudoum
Aurelia Djeumako Mbossi
Charles Kouanfack
Raspail Carrel Founou
author_facet Ravalona Jessica Zemtsa
Michel Noubom
Luria Leslie Founou
Brice Davy Dimani
Patrice Landry Koudoum
Aurelia Djeumako Mbossi
Charles Kouanfack
Raspail Carrel Founou
author_sort Ravalona Jessica Zemtsa
collection DOAJ
description The exacerbation of antimicrobial resistance (AMR) is a major public health threat worldwide. In sub-Saharan Africa, there is a scarcity of data regarding multidrug-resistant (resistance to at least one antibiotic of three or more families of antibiotics) as well as extended spectrum β-lactamase-producing <i>Enterobacterales</i> (ESBL-PE), isolated among clinical and asymptomatically healthy patients, especially in women living with HIV (WLHIV) despite their immunocompromised status. The overarching aim of this study was set to determine the prevalence and characterize genotypically multi-drug resistant <i>Enterobacterales</i> (MDR-E) and ESBL- PE isolated from vaginal swabs of WLHIV attending the Yaoundé Central Hospital, Yaoundé, Cameroon. A cross-sectional study was conducted among WLHIV during a four-month periods from 1 February to 31 May 2021. A total of 175 WLHIV, of childbearing age and under antiretroviral treatment were contacted. One hundred and twenty participants (120) were recruited and vaginal swabs were collected from them. After culture on Eosine-Methylen Blue (EMB) agar, the identification of <i>Enterobacterales</i> was performed using API 20E kit. A double-screening of ESBL-PE was performed using a combined disc diffusion method and ROSCO Diagnostica kits. An antibiotic susceptibility test was carried out by disc diffusion as per the Kirby-Bauer method and the β-lactamase resistance genes, <i>bla</i><sub>CTX-M</sub>, <i>bla</i><sub>CTX-M-group1-2-9</sub>, <i>bla</i><sub>TEM</sub> were molecularly characterized using a conventional Polymerase Chain Reaction (PCR). Overall, 30.83% (37/120) of the included WLHIV were colonized <i>with Enterobacterales</i> and the prevalence of vaginal carriage of MDR <i>Enterobacterales</i> among them was 62.16% (23/37). Among MDR-E isolates, the most prevalent species were <i>E. coli</i> (56.0%; 14/25) and <i>K. pneumoniae</i> (20.0%; 5/25). High rates of resistance to trimethoprim-sulfamethoxazole (96.0%; 24/25), amoxicillin-clavulanic acid (88.0%; 22/25) and gentamicin (72%; 18/25) were observed. The resistance mechanisms detected among these isolates were ESBL (48.0%; 12/25), ESBL+ porin loss (8.0%; 2/25), ESBL+AmpC (24%; 6/25), with <i>bla</i><sub>CTX-M</sub>, <i>bla</i><sub>CTX-M-group-1,2,9</sub> being identified at 48.0% (12/25) for each of them and <i>bla</i><sub>TEM</sub> at 72.0% (18/25). Our findings confirm the high-prevalence of MDR as well as ESBL-PE isolated in WLHIV, and suggest that a real time monitoring system of antimicrobial resistant bacteria coupled with the reinforcement of infection prevention control (IPC) strategies are needed to sustainably contain these life-threatening pathogens especially in the most vulnerable populations.
first_indexed 2024-03-10T03:12:07Z
format Article
id doaj.art-1e25a2991b444c34b64a5597ede0f359
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T03:12:07Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-1e25a2991b444c34b64a5597ede0f3592023-11-23T12:31:39ZengMDPI AGPathogens2076-08172022-04-0111550410.3390/pathogens11050504Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, CameroonRavalona Jessica Zemtsa0Michel Noubom1Luria Leslie Founou2Brice Davy Dimani3Patrice Landry Koudoum4Aurelia Djeumako Mbossi5Charles Kouanfack6Raspail Carrel Founou7Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang P.O. Box 96, CameroonFaculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang P.O. Box 96, CameroonReproductive, Maternal, Newborn and Child Health (ReMARCH) Research Unit, Research Institute of Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM-RI), Yaoundé P.O. Box 67, CameroonDepartment of Biomedical Sciences, Higher Institute of Medical Technology, Nkolondom, Yaoundé P.O. Box 188, CameroonFaculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang P.O. Box 96, CameroonReproductive, Maternal, Newborn and Child Health (ReMARCH) Research Unit, Research Institute of Centre of Expertise and Biological Diagnostic of Cameroon (CEDBCAM-RI), Yaoundé P.O. Box 67, CameroonFaculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang P.O. Box 96, CameroonFaculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang P.O. Box 96, CameroonThe exacerbation of antimicrobial resistance (AMR) is a major public health threat worldwide. In sub-Saharan Africa, there is a scarcity of data regarding multidrug-resistant (resistance to at least one antibiotic of three or more families of antibiotics) as well as extended spectrum β-lactamase-producing <i>Enterobacterales</i> (ESBL-PE), isolated among clinical and asymptomatically healthy patients, especially in women living with HIV (WLHIV) despite their immunocompromised status. The overarching aim of this study was set to determine the prevalence and characterize genotypically multi-drug resistant <i>Enterobacterales</i> (MDR-E) and ESBL- PE isolated from vaginal swabs of WLHIV attending the Yaoundé Central Hospital, Yaoundé, Cameroon. A cross-sectional study was conducted among WLHIV during a four-month periods from 1 February to 31 May 2021. A total of 175 WLHIV, of childbearing age and under antiretroviral treatment were contacted. One hundred and twenty participants (120) were recruited and vaginal swabs were collected from them. After culture on Eosine-Methylen Blue (EMB) agar, the identification of <i>Enterobacterales</i> was performed using API 20E kit. A double-screening of ESBL-PE was performed using a combined disc diffusion method and ROSCO Diagnostica kits. An antibiotic susceptibility test was carried out by disc diffusion as per the Kirby-Bauer method and the β-lactamase resistance genes, <i>bla</i><sub>CTX-M</sub>, <i>bla</i><sub>CTX-M-group1-2-9</sub>, <i>bla</i><sub>TEM</sub> were molecularly characterized using a conventional Polymerase Chain Reaction (PCR). Overall, 30.83% (37/120) of the included WLHIV were colonized <i>with Enterobacterales</i> and the prevalence of vaginal carriage of MDR <i>Enterobacterales</i> among them was 62.16% (23/37). Among MDR-E isolates, the most prevalent species were <i>E. coli</i> (56.0%; 14/25) and <i>K. pneumoniae</i> (20.0%; 5/25). High rates of resistance to trimethoprim-sulfamethoxazole (96.0%; 24/25), amoxicillin-clavulanic acid (88.0%; 22/25) and gentamicin (72%; 18/25) were observed. The resistance mechanisms detected among these isolates were ESBL (48.0%; 12/25), ESBL+ porin loss (8.0%; 2/25), ESBL+AmpC (24%; 6/25), with <i>bla</i><sub>CTX-M</sub>, <i>bla</i><sub>CTX-M-group-1,2,9</sub> being identified at 48.0% (12/25) for each of them and <i>bla</i><sub>TEM</sub> at 72.0% (18/25). Our findings confirm the high-prevalence of MDR as well as ESBL-PE isolated in WLHIV, and suggest that a real time monitoring system of antimicrobial resistant bacteria coupled with the reinforcement of infection prevention control (IPC) strategies are needed to sustainably contain these life-threatening pathogens especially in the most vulnerable populations.https://www.mdpi.com/2076-0817/11/5/504antibiotic resistanceEnterobacteralesHIVMDRESBLsCameroon
spellingShingle Ravalona Jessica Zemtsa
Michel Noubom
Luria Leslie Founou
Brice Davy Dimani
Patrice Landry Koudoum
Aurelia Djeumako Mbossi
Charles Kouanfack
Raspail Carrel Founou
Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
Pathogens
antibiotic resistance
Enterobacterales
HIV
MDR
ESBLs
Cameroon
title Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
title_full Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
title_fullStr Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
title_full_unstemmed Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
title_short Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing <i>Enterobacterales</i> Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
title_sort multidrug resistant and extended spectrum β lactamase esbl producing i enterobacterales i isolated from carriage samples among hiv infected women in yaounde cameroon
topic antibiotic resistance
Enterobacterales
HIV
MDR
ESBLs
Cameroon
url https://www.mdpi.com/2076-0817/11/5/504
work_keys_str_mv AT ravalonajessicazemtsa multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT michelnoubom multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT lurialesliefounou multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT bricedavydimani multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT patricelandrykoudoum multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT aureliadjeumakombossi multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT charleskouanfack multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon
AT raspailcarrelfounou multidrugresistantandextendedspectrumblactamaseesblproducingienterobacteralesiisolatedfromcarriagesamplesamonghivinfectedwomeninyaoundecameroon